Regeneron Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Regeneron Pharmaceuticals's balance sheet done over the years? Its assets were worth $33,080,199,999 last year, which is more than in the previous period. 21% of Regeneron Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $7,107,100,000, which means an increase by 8% compared compared to last year.
Debt to Assets
| 2014 | 3871827000 | 1.32B | 34.34% |
|---|---|---|---|
| 2015 | 5609132000 | 1.95B | 34.84% |
| 2016 | 6973466000 | 2.52B | 36.2% |
| 2017 | 8764286000 | 2.62B | 29.9% |
| 2018 | 11734500000 | 2.97B | 25.37% |
| 2019 | 14805200000 | 3.71B | 25.1% |
| 2020 | 17163300000 | 6.13B | 35.76% |
| 2021 | 25434800000 | 6.66B | 26.21% |
| 2022 | 29214500000 | 6.55B | 22.42% |
| 2023 | 33080199999 | 7.10B | 21.48% |
REGN Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 2.73B | 3.10B | 2.88B | 2.19B | 1.61B | 1.46B | 812.73M | 535.20M | 809.10M | 648.71M |
Short term investments | 8.11B | 4.63B | 2.80B | 1.39B | 1.59B | 1.34B | 596.84M | 503.48M | 236.12M | 251.76M |
Net receivables | 5.66B | 5.32B | 6.03B | 4.11B | 2.67B | 2.24B | 1.97B | 1.61B | 1.46B | 976.37M |
Inventory | 2.58B | 2.40B | 1.95B | 1.91B | 1.41B | 1.15B | 726.13M | 399.35M | 238.57M | 128.86M |
Other current assets | 386.6M | 933M | 332.4M | 1.16B | 959.3M | 243.3M | 450.07M | 130.52M | 163.50M | 161.74M |
Total current assets | 19.47B | 22.06B | 20.52B | 12.75B | 10.55B | 7.95B | 5.59B | 3.91B | 3.38B | 2.50B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 4.22B | 3.76B | 3.48B | 3.22B | 2.89B | 2.57B | 2.35B | 2.08B | 1.59B | 974.30M |
Goodwill | 0 | 0 | -6.84B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 1.03B | 915.5M | 6.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 5.39B | 5.40B | 6.83B | 3.13B | 3.25B | 1.75B | 1.48B | 864.26M | 632.16M | 460.15M |
Other non-current assets | 366.10M | -4.65B | 555.2M | 328.9M | 531.8M | 370.7M | 302.83M | 150.82M | 169.31M | 74.52M |
Total non-current assets | 13.60B | 7.14B | 4.91B | 4.40B | 4.24B | 3.77B | 3.16B | 3.05B | 2.22B | 1.36B |
Total assets | 33.08B | 29.21B | 25.43B | 17.16B | 14.80B | 11.73B | 8.76B | 6.97B | 5.60B | 3.87B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 458.9M | 547.7M | 442M | 577.7M | 591.7M | 452.5M | 320.13M | 231.66M | 153.48M | 74.02M |
Short term debt | 0 | 720M | 719.7M | 1.63B | 0 | -90.8M | 0 | 127.27M | 0 | 0 |
Total current liabilities | 3.42B | 3.84B | 3.45B | 2.80B | 1.79B | 1.35B | 967.41M | 980.65M | 760.61M | 620.13M |
| Non-current liabilities: | ||||||||||
Long term debt | 2.70B | 2.70B | 2.69B | 2.69B | 713.9M | 708.5M | 703.5M | 481.12M | 362.91M | 457.71M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 854.1M | -128M | 680.2M | 687.1M | 286M | 502M | 949.29M | 100.38M | 115.53M | 217.13M |
Total non-current liabilities | 3.68B | 2.70B | 3.21B | 3.33B | 1.92B | 1.62B | 1.65B | 1.54B | 1.19B | 709.36M |
Total liabilities | 7.10B | 6.55B | 6.66B | 6.13B | 3.71B | 2.97B | 2.62B | 2.52B | 1.95B | 1.32B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |